OmicScouts GmbH

Great to see this published!! Congrats to our collaborators at Bayer and the DKFZ, in particular Gabriele Leder, Jeffrey Mowat and Rienk Offringa! MAP4K1 (also known as HPK1) is a an attractive immune-oncology target for inducing therapeutic T-cell responses in cancer patients! OmicScouts is proud of contributing to this excellent study, in which our KinomeScout™ technology enabled selectivity profiling of the lead compound BAY-405 across cellular kinases of relevant biological systems! Read more about our KinomeScout assay here: https://lnkd.in/dgpTRvGr #Bayer #DrugDiscovery #Proteomics

Meet OmicScouts BD to talk about target deconvolution, target occupancy studies and all new pharmacological interventions: RNAi, degraders / mol. glues and PROTACS, or any other needs for (chemical) proteomics services. You can also reach out to us via LinkedIn or at [email protected]

Who will be at the EFMC-ISMC in Rome next week? Looking forward to seeing you there! If you´re wondering about target deconvolution, protein turnover or MoA analysis, let´s meet in the exhibition area and talk (chemo) proteomics! www.omicscouts.com // [email protected] #EFMC #MedicinalChemistry #DrugDiscovery

Great discussion and fantastic science at the ELRIG Research & Innovation conference in Manchester. #ELRIG #RI2024

We're #hiring a new IT-System Administrator (m/f/d) in Freising, Bavaria. Apply today or share this post with your network. 💼✨ #Karriere #Bewerbung #Jobs

Hello dear community 🎉 We hope that 2024 has brought you inspiring moments so far! 🌈 In this context, we'd like to share something personal with you and encourage you to do the same: Have you set resolutions for this year, especially concerning your mental health? 🤔 At OmicScouts, we not only value professional goals but also the well-being of our team members. The year can be stressful, and it's essential that we collectively take care of our mental health. 😌 How are you doing in that regard? Do you have personal strategies or tips for enhancing your mental well-being? We look forward to hearing about your experiences and engaging in a conversation in the comments! 💬 Together, we can build a supportive community and inspire each other to set goals that align with both our professional and mental health. 💪 Let's shape a year of balance and growth together! 🌱 #MentalHealth #TeamBalance #Resolutions2024 #TogetherStrong #CompanyName

OmicScouts is honored to support this excellent conference on covalent drug discovery and to present alongside a prominent line-up of speakers. We are looking forward to novel insights and great discussions.

Thank you for that very interesting webinar by Factorial and Dr. Eva Elisa Schneider today! 👏 My biggest take away: 🧠 Mental health is not inherent, it is a skill. It can be learned, cultivated and developed!

Happy New Year! 🍀🍀🍀 As we usher in 2024, we are excited about propelling your next-generation drug discovery endeavors with our expertise and services in proteomics and chemical proteomics. Reflecting on 2023, we are proud to announce a significant expansion of our service offerings. Introducing two groundbreaking technologies: 🎯 SideScout™: Revolutionizing target deconvolution and target engagement analysis in living cells. SideScout™ is a label-free and proteome-wide denaturation shift assay to track drug action in living cells. 🧬 NucleoBeads™: Enabling global interaction profiling of transcription factors and DNA-binding proteins through nucleotide affinity chromatography. Our proprietary NucleoBeads allow the reproducible quantification of DNA binding for over 300 transcription factors and DNA binding proteins, including p53, NFkB, and MYC, under physiological conditions. Additionally, we are proud to unveil our latest achievement - the comprehensive Protein Turnover Atlas 📖. Covering over 14,000 human proteins across 30 diverse cell lines and types, this resource provides invaluable insights into protein degradation and re-synthesis rates. Crucial for the success of emerging chemical modalities like covalent drugs, the Atlas is accessible under a limited use license. Explore our website for more details on our cutting-edge chemical proteomics technologies. To all our esteemed past, present, and future clients, we extend warm wishes for a Happy New Year and are looking forward to the opportunity to collaborate with you throughout 2024!

🌟 New Year, New Perspectives! 🌟 For 2024, we at OmicScouts GmbH, have set the goal to prioritize the mental health of our employees even more. A healthy work-life balance and a supportive work environment are not only crucial for the well-being of each individual but also for the collective success of our team. 🤝 To take the first step in this direction, we have launched a survey on psychological risk assessment. This will help us to develop and implement targeted measures to promote the mental health of our employees. 📊 Mental health in the workplace brings numerous advantages: 🧠 Increased Productivity: Satisfied and balanced employees are proven to be more productive. 🤝 Stronger Team Bonding: A supportive environment fosters team spirit and collaboration. 🌈 Innovation: Creative ideas and innovative solutions thrive in a positive work atmosphere. 📈 Reduced Absenteeism: Employees who feel well are less likely to be absent and more motivated. What are your thoughts? Which measures do you find particularly effective in promoting mental health in the workplace? 💭 Share your thoughts and experiences in the comments – let's contribute together to a supportive and healthy work environment! 🌱 #MentalHealth #WorkplaceCulture #StrongerTogether